Most Read Articles
Roshini Claire Anthony, 13 Jun 2019

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.
Pearl Toh, 5 days ago
Adding apalutamide to androgen-deprivation therapy (ADT) significantly extends radiographic progression-free survival (rPFS) and overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) compared with ADT alone, the TITAN* study shows.
13 Jun 2019
A brief cognitive behavioural therapy intervention neither improves psychological health nor cuts representation of patients with a history of noncardiac chest pain, reports a new study.

Product Highlight - VaxigripTetra

29 Mar 2019
  • Active Ingredient: Quadrivalent influenza vaccine (split virion, inactivated)
  • Indications: Prevention of influenza in children and adults.
  • Dosage & Administration:
    • The vaccine should be given by intramuscular or subcutaneous injection.
    • Children from 6 months of age and older should receive one dose of 0.5 mL.
    • For children less than 9 years old and have never received influenza vaccine before, the second dose of 0.5 mL should be given at 4 weeks after the first dose.
  • Presentation: Suspension for Injection in pre-filled syringe 0.5 mL.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 13 Jun 2019

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

6 days ago
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.
Pearl Toh, 5 days ago
Adding apalutamide to androgen-deprivation therapy (ADT) significantly extends radiographic progression-free survival (rPFS) and overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) compared with ADT alone, the TITAN* study shows.
13 Jun 2019
A brief cognitive behavioural therapy intervention neither improves psychological health nor cuts representation of patients with a history of noncardiac chest pain, reports a new study.